Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
Phase 1
Terminated
- Conditions
- Breast CancerUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-11-09
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- Wiseman Research Initiatives LLC
- Target Recruit Count
- 24
- Registration Number
- NCT00095862
- Locations
- 🇺🇸
Glendale Memorial Hospital Comprehensive Cancer Center, Glendale, California, United States
🇺🇸Hollywood Presbyterian Medical Center, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath